Bariatric Surgery Market Projected to Deliver Greater Revenues By 2023

The global bariatric surgery market is expected to exhibit a robust 6.5% CAGR over the forecast period, according to a new research report from Market Research Future (MRFR). The global bariatric surgery market is driven mainly by the growing demand for bariatric surgeries from the urban population in developed economies. The growing prevalence of obesity in urban centers in the West is likely to drive the global bariatric surgery market over the forecast period.

Bariatric surgery is performed to pinch off the patient’s stomach so that their food intake is reduced without compensating on their hunger. Bariatric surgery is mostly performed in individuals with a body mass index of more than 40. Thus, cases of intense obesity with a chance of turning into morbid obesity are mostly the ideal application for bariatric surgeries.

The growing prevalence of obesity around the world is likely to be the major driver for the global bariatric surgery market over the forecast period. The global prevalence of obesity has been driven in the last few decades by the growing popularity of junk food and the growing prevalence of a sedentary lifestyle that doesn’t provide for exercise and active recreation. Bariatric surgery is one of the most direct ways of combating obesity, as the capacity for food intake is itself reduced, leading to smooth weight loss after the surgery.

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/5693

Advances in bariatric surgery are also likely to drive the demand for bariatric surgery over the forecast period. The growing demand for minimally invasive surgeries is likely to drive innovation in the bariatric surgery market over the forecast period, as manufacturers rush to fulfill the customer demand in the most efficient way possible. The growing number of patients opting for bariatric surgery is likely to drive the global bariatric surgery market over the forecast period.

Competitive Analysis:

Leading players in the global bariatric surgery market include Apollo Endosurgery Inc., Olympus Corporation, TransEnterix Surgical Inc., EndoGastric Solutions Inc., Medtronic, Aspire Bariatrics, Mediflex Surgical Products, Intuitive Surgical, ReShape Lifesciences Inc., Cousin Biotech, Allergan, and Johnson & Johnson Services Inc.

Segmentation:

The global bariatric surgery market is segmented on the basis of device, type, and end user.

On the basis of the device, the bariatric surgery market is segmented into surgical stapler gastric bands, gastric balloons, gastric emptying systems, electrical stimulation systems, and others.

On the basis of the type, the market is segmented into gastric bypass, sleeve gastrectomy, adjustable gastric band, biliopancreatic diversion with duodenal switch, and others.

On the basis of the end user, the bariatric surgery market is segmented into hospital & clinics, surgical centers, and others.

Regional Analysis:

The Americas hold the major share in the global bariatric surgery market due to the high prevalence of obesity in the region. The global bariatric surgery market is likely to receive strong demand from North America in the coming years due to the growing prevalence of obesity among the urban as well as rural populations in the region. The growing awareness among consumers in the region about maintaining an attractive appearance is also likely to lead to a steady rise in the bariatric surgery market in the region over the forecast period. The high disposable income of consumers in the region is also likely to be a major driver for the global bariatric surgery market over the forecast period. According to the CDC, one third of the U.S. population were obese in 2014, leading to strong prospects for the bariatric surgery market in the region.

Europe is also likely to emerge as a major regional market for bariatric surgery in the coming years due to the growing prevalence of obesity in advanced Western economies and the growing availability of government funding for research.

Asia Pacific holds a relatively small share in the global bariatric surgery market, but is likely to exhibit rapid growth over the forecast period, mainly due to the growing prevalence of diabetes in the region.

Table Of Content 

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

...Conitnued

Get full report & TOC @: https://www.marketresearchfuture.com/reports/bariatric-surgery-market-5693

Radiotherapy Market to expand at a CAGR of 7% by 2023

Radiotherapy, also known as Radiation therapy is largely used in cancer treatment and less commonly in the treatments of thyroid disease, blood disorders, and noncancerous growths. Radiotherapy uses high-energy rays to treat the conditions.

Radiotherapy is a proven effective cancer treatment and hence, its market is growing rapidly and pervasively. Technological advancements in medical science & biotechnology have improved the outlook for cancer treatments further escalating the market on the global platform, controlling the spread of the disease sufficiently.

Acknowledging the exponential accruals, the market is garnering pervasively, Market Research Future (MRFR) in its recently published study report asserts that the global Radiotherapy market is poised to touch a valuation of USD 7 MN by 2023

registering a CAGR over 7% during the forecast period (2017 – 2023).  In 2016, the market had valued at 4.5 MN. which indicates that the market is expected to achieve a slightly lesser than the double fold growth.

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/1526

Worldwide, cancer cases are increasing pervasively, creating a million dollar concern. On the other hand, Improving economy is proving to be a blessing in disguise that is in a way increasing the purchasing power of people, increasing the access to the modern life that is leading to the growing addictions such as tobacco and alcoholism which are the dominant risk factor developing cancer cells and tumors. And, on the other hand, these improving economic conditions are increasing access to the quality of healthcare, increasing the number of treatment centers.

Additionally, factors such as the increasing per capita healthcare expenditures, increasing population, exposures to harmful radiation, heredity reasons, and genetic mutations are driving the growth of the Radiotherapy market. Increasing governmental initiatives are supporting the market growth, spreading the awareness towards cancer and its treatments. Unavailability of comprehensive treatments especially in the developing regions presages the large scope for the market to evolve further, prompting substantial investments for R&D to bring more novelty and betterments in the radiology.

On the flip side, high costs associated with the radiotherapy, long approval time for the clinical trials along with the adverse effects associated with therapy are obstructing the market growth.  

Global Radiotherapy Market – Segmentations

The MRFR analysis is segmented into three key dynamics for enhanced understanding. 

By Treatment Type: Proton Therapy and X-rays, External Beam Radiotherapy (Intensity Modulated Radiation Therapy (IMRT), 3D Conformal Radiation Therapy, Image Guided Radiation Therapy (IGRT), Stereotactic Radio Surgery, Tomotherapy, and Stereotactic Body Radiation Therapy.), others.

By Application: Prostate Cancer, Breast Cancer, Lung Cancer, and others.

By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World. 

Global Radiotherapy Market – Regional Analysis

The North American region is estimated to continue dominating the global Radiotherapy market, slicing the largest market share.  Majorly supported by the US, the growth in the market is fostered by the increasing prevalence of various types of cancer and thyroid as a result of the consequences of the wrong lifestyle, in the region.  Moreover, technological advances coupled with the increasing healthcare expenditure support the growth of the regional market.

The Radiotherapy market in the European region is expected to account for the second-largest market, following the North American market closely. Factors boosting the growth of the regional market include technological advancement and the augmented adoption of Radiotherapy to treat the growing cases of cancer occurrences.

The Asia Pacific region, heading with the improving economic conditions that are rapidly increasing the access to the quality healthcare is rapidly emerging as a profitable market for Radiotherapy.

Moreover, the increasing number of cancer patients in the region alongside the advancements in medical technology drives the market growth in the region. 

Global Radiotherapy Market – Competitive Analysis

The Radiotherapy market appears to be highly competitive characterized by the presence of several well-established as well as small players. Matured players incorporate strategic initiatives such as acquisition, collaboration, partnership, expansion, and technology launch in order to gain a competitive advantage and thus to maintain their positions in this market. 

Well-established players are increasingly investing in R&D to develop a cost-effective product portfolio and are seeking expansion through various strategic initiatives. These players tap the growing markets for expansions and strive to address the critical needs of the market with a broad range of solutions and effective and complete workflow.

Key Players:

Key players leading the global Radiotherapy market include Siemens (Germany), Varian (India), GE Healthcare (UK), Cardinal Health (US), Nordion (CA), Isoray (US), View ray (US), Fuji Holdings (Japan), Philips Healthcare (US), Shimadzu Corporation (Japan), and Hologic (US).

Industry/ Innovation/Related News:

January 25, 2019 --- Apollo Hospitals Enterprise Limited (India), a leading hospital chain launched SE Asia's first proton cancer center - Apollo Proton Cancer Centre (APCC), which would offer Proton beam therapy considered as one of the most superior forms of radiation therapy in the treatment of cancers.

It is the first institution to offer advanced cancer treatment in Southeast Asia.  Unlike the conventional radiotherapy, Proton Therapy uses high energy proton beam (sub-atomic particles) to achieve the same impact but without the collateral damage.

January 16, 2019 --- MIM Software Inc. (the US), a leading global provider of medical imaging software solutions in the fields of radiation brachytherapy, oncology, radiology, and clinical trials among others announced receiving of FDA 510(k) clearance for its molecular radiotherapy (MRT) dosimetry.

MRT, an effective form of therapy that using radiopharmaceuticals such as Azedra (I-131 iobenguane) and Lutathera (Lu-177 DOTATATE) targets tumors based on certain receptors that these tumors express. 

Get full report & TOC @: https://www.marketresearchfuture.com/reports/radiotherapy-market-1526

Ayurveda Market Shares Analysis, Key Development Strategies and Forecasts Till 2023

Alternative medicine such as ayurveda is gradually entering the mainstream. Be it reduced side effects or low cost, ayurveda is gaining commercial success of late. Market Research Future (MRFR) has recently published an in-depth report on the global ayurveda market, where growth avenues are discussed at length. As per the analysis of MRFR, the ayurveda market is anticipated to register a moderate CAGR over the forecast period of 2017-2023.

The longstanding tradition of ayurvedic healing is now being recognized worldwide. Ayurveda has been able to gain commercial interest as the global populace is inclining towards organic and pure stuff. The efficacy of ayurveda is being evidenced by its efficacy in treating medical problems ranging from cardiovascular diseases, skin problems, diabetes, cancer, depression to sexual problems. The failure of modern medicine and side effects associated with them is further creating a supportive dais for the growth of the market.

With more players foraying into the ayurveda space, the global ayurveda market is poised for significant growth. new ayurveda companies are aggressively indulging in promotional activities, which has been able to evoke awareness among consumers. Furthermore, the governments of various countries are drafting ayurveda-friendly policies which is furthering the growth of the market.

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/6166

Ayurveda has gained enormous popularity in medical tourism. As the benefits of ayurveda is becoming more visible, the trend of ayurveda medical tourism is consolidating. Various hospitals are increasingly catering to the ayurveda segment, with renowned doctors associated with them. Additionally, people across the globe are increasingly shifting to a preventive healthcare approach. Lately, people from across the globe are looking forward to wellness tourism and India has become an ayurveda & wellness hotspot.

However, the global ayurveda market might face some setbacks in the light of various impeding factors. Such factors include lack of scientific validation for ayurveda in developed countries, lack of proper regulatory framework, and the notion among people that ayurveda is a pseudoscience. other factors are lack of trained ayurveda professionals, unavailability of reimbursements, and lack of awareness.

Segmentation

The ayurveda market has been segmented based on application, disease pattern, source, form, end user, and distribution.

By application, the ayurveda market has been segmented into medicinal, personal care and other.

By disease pattern, the ayurveda market has been segmented into respiratory system, nervous systems, gastrointestinal track, cardiovascular system, infectious diseases, skeletal system, skin and hair, others.

By source, the ayurveda market has been segmented into vegetable (leaves and fruit, seeds, roots, bark and other) and animal (oils, bones, and other).

By form, the ayurveda market has been segmented into herbal, herbomineral, mineral and others.

By end user, the ayurveda market has been segmented into academia and research, hospitals and clinics, over and others.

By distribution, the ayurveda market has been segmented into organized, over the counter and others. 

Regional Analysis

Region-wise, the ayurveda market has been segmented into North America, the Middle & Africa (MEA), Europe, and Asia Pacific (APAC).

APAC is at the forefront of the global ayurveda market. Ayurveda originated in India, due to which the market has a strong foothold in the region. Ayurveda is immensely popular in India and allied countries of the region, where it is indigenous to their culture. Other key contributors to the APAC ayurveda market include Nepal, Japan, Sri Lanka, Indonesia, Myanmar and Pakistan. India is the largest ayurveda market within APAC and currently stands at USD 1200 Mn. In 2016, ayurveda drugs worth USD 64 Mn were exported from India.

With the surging popularity of ayurveda across the globe, the market is expanding from all sides. In both North America and Europe, ayurveda is gaining traction on account of heightened demand for natural therapies. The key country-specific markets within Europe includes Russia, France, Germany, and the UK, while, the US is the largest market within North America. Other significant ayurveda markets include Kazakhstan, Ukraine, Philippines, Kenya and Mauritania.

The MEA ayurveda market is poised to showcase moderate growth in the coming years. Ayurvedic therapies are gaining grounds in the region, especially in Africa due to its cost effectiveness. The Gulf countries are also responsible for generating a considerable portion of the global demand.

Competitive Landscape

Emami Group, Charak Pharma, Patanjali Ayurved Ltd., Dabur, Hamdard Laboratories, Baidyanath Group, Zandu Pharmaceutical Works Ltd., and Vicco Labs are the eminent players in the global ayurveda market.

TABLE OF CONTENT 

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

....Continued

Get full report & TOC @: https://www.marketresearchfuture.com/upcoming-reports/ayurveda-market-6166

Vascular Closure Devices Market to Witness Significant Incremental Opportunity By 2023

Market Research Future published a half-cooked research report on the global vascular closure devices market.

Market Highlights

It is estimated that the global vascular closure devices market is expected to register a CAGR ~ 6.8% during the forecast period of 2018–2023. The global vascular closure devices market is expected to witness tremendous growth owing to the rising prevalence of numerous types of cardiovascular as well as neurovascular diseases. Other key factors such as the untapped market opportunities in emerging countries, growing investments by government organizations, increasing adoption rate of minimally invasive techniques are contributing towards the growth of the market. However, factors such as lack of trained medical professionals, and the post-operative complications are expected to curb the growth of the market during the forecast period.

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/5704

On the regional basis, the vascular closure devices market in the Americas is predicted to dominate the market during the forecast period. The North American region holds substantial share in the global market. This owes to the rise in the government initiatives, and the increased prevalence of coronary diseases in these regions. For instance, according to the data published in 2015 by the American Heart Association (AHA), about one in 7 deaths in the US is caused by coronary heart disease. Also, numerous major players are based in the US, owing to which the US has become a center for innovation in the vascular closure devices market.

Currently, the global vascular closure devices market is dominated by numerous players. The major players in this market are involved in new product launches, strategic partnerships and collaborations to increase their product portfolio. For example, in June 2018, Biomerics, a medical device contract manufacturer announced the acquisition of FutureMatrix Interventional, Inc. The company aims to expand its portfolio of interventional catheters used in cardiovascular and urology fields, thus strengthening its position in the market.

The global vascular closure devices market is segmented on the basis of product type, access, procedures, application, and end user.

Some of the key players in the global intraocular lens market are Abbott Laboratories, Terumo Corporation, Cardinal Health Inc., Cardiva Medical Inc., Morris Innovative, Inc., Medtronic plc, Essential Medical, Inc., Merit Medical Systems, Inc., TZ Medical, Inc., Vasorum Ltd., Transluminal Technologies LLC, Vascular Closure Systems, Inc., Vivasure Medical Ltd., among others.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

....Continued

Get full report & TOC @: https://www.marketresearchfuture.com/reports/vascular-closure-devices-market-5704

Laxatives Market Witness Rapid Increase in Consumption By 2022

Market Synopsis:

Laxatives are used for treating constipation. Increasing cases of gastrointestinal disorders are expected to boost the demand for laxatives over the next couple of years. The study conducted by Market Research Future (MRFR) has highlighted that the global laxatives market is anticipated to expand at a moderate CAGR across the assessment period 2017 to 2022.

Laxatives are available without prescriptions over the OTC counters. People are aware of the effects which are likely to accelerate revenue creation for the market players. The growth pace of the pharmaceutical industry is also prognosticated to facilitate the expansion of laxatives market in the years to come.

The paradigm shift towards a sedentary lifestyle is anticipated to increase the burden of constipation. Also, increasing dependency on unhealthy food pattern is poised to facilitate the exponential growth of patient population in the forthcoming years. On the flip side, adverse effects associated with the medicine such as cramps, dehydration, etc. is anticipated to undermine the growth of the laxatives market over the next few years.

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/2772

Market Segmentation:

Global Laxatives market, on the basis of the mechanism of action, has been segmented into bulk forming, stimulant, osmotic, emollient, and others.

On the basis of type, the laxatives market has been bifurcated into organic and synthetic.

On the basis of route of administration, the global laxatives market has been bifurcated into oral and rectal.

Regional Analysis:

The global laxatives market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA). Among these regional segments, North America has been projected to account for the maximum share of the market through the review period. The U.S, and Canada are expected to contribute remarkably towards the development of the regional laxatives market in the forthcoming years. One of the primary factors inducing market growth is the sedentary lifestyle adopted by the population in the region. It is also expected to increase the burden of obesity, which is projected to have a favorable impact on the rising patient population of constipation. The food pattern of the region is also highly unhealthy. This, in turn, is likely to catapult the laxatives market on its growth trajectory.

Europe is forecasted to maintain its stand at the second spot over the next couple of years. Europe is anticipated to benefit from the increasing cases of irritable bowel syndromes witnessed in the region. This, in turn, is anticipated to boost the sales of laxatives in the years to come. The region has also been observing a drastic change in the lifestyle of the people. The dependency on an unhealthy diet, in conjunction with a physically inactive lifestyle, is expected to favor the expansion of the laxatives market over the next few years. In addition, the availability of laxatives without prescription over the OTC counters is poised to optimize the growth of the market in the region across the review period.

Asia Pacific is prognosticated to exhibit rapid developments over the next few years. The growth of the regional segment can be ascribed to the exponentially increasing population. A drastic rise in the patient population is expected owing to increasing population, which is projected to drive the growth of the region in the years to come. Also, the advancements in the healthcare industry are likely to boost the expansion of the industry over the next few years. The Middle East & Africa is projected to exhibit developmental opportunities. However, lack of access to standard medical services in certain regions, especially in Africa, is poised to restrict the growth of the regional segment.

Competitive Dashboard:

The key participants profiled in the share analysis of the global laxatives market are AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, GlaxoSmithKline, Takeda Pharmaceutical Company, and Abbott Laboratories. 

Get access to full Report @ https://www.marketresearchfuture.com/reports/laxatives-market-2772

Psoriasis Treatment Market Going to Reach US$10.68 billion by the End of 2022

Market Synopsis

Market Research Future (MRFR) proclaims that the psoriasis treatment market is estimated to garner USD 10.68 billion, grabbing a CAGR of 7.3% during the forecast period (2016-2022). The rising risk factors like the autoimmune disease is likely to contribute to the market growth. Psoriasis can be referred to as a chronic non-contagious disease in which an individual’s immune system sends faulty signals which directs the skin cells to develop too quickly. New skin cells thus get formed in days rather than weeks which results in the skin to pile up on the surface, thereby causing patches of psoriasis. It can also affect the nails and fingers which leads to partial disability and painful disfiguration. The disease mainly affects the elbows, knees, and scalp. It can occur at any age, but persons from 50-70 years of age are most affected.

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/2769

Market Potential and Pitfalls

The fact that the exact etiology and cause of psoriasis is still unknown, genetics, auto-immunity, and environmental factors are the root causes. It is related to a host of co-morbidities like ophthalmologic pathologies, psoriatic arthritis, inflammatory bowel disease, and diabetes. As per WHO, 1.3% to 34.7% of the individuals suffering from psoriasis tend to develop chronic psoriatic arthritis which results in the deformation and disability of the joints. The rising screening and surging incidences of psoriasis are considered the top factors are propelling the psoriasis treatment market. With the growing risk factors like diabetes and autoimmune diseases coupled with the exposure to environmental factors like allergens and chemicals, the market is likely to evolve in the coming years.

Several treatments are available in the market which helps to control the symptoms of psoriasis, thereby inflating the growth over the years. The treatment methods include administering vitamin D3, steroid, immunosuppressive like methotrexate, and exposure to ultraviolet B (UVB) light. Ointments and creams of calcipotriol and corticosteroid are known to treat mild-to-moderate psoriasis effectively.

On the contrary, the dearth of permanent and effective treatment for psoriasis is considered to dampen the market growth across the globe. As there is as such no cure for psoriasis, most of the treatments are either temporary or symptomatic. Moreover, the patent expiry of blockbuster drugs like Enbrel, Humira, and Remicade, high cost of drug development, and side effects related to medications like liver and kidney damage and hypertension are considered to vitiate the market growth.

Global Psoriasis Treatment Market: Segmental Analysis

The global psoriasis treatment market has been segmented on the basis of route of administration, mechanism of action, and by drug types.

By mode of mechanism of action, the global psoriasis treatment market has been segmented into phosphodiesterase inhibitors, interleukin blockers, TNF inhibitors, and others. Among these, TNF inhibitors are likely to gain prominence in the psoriasis treatment market.

By mode of administration, the global psoriasis treatment market has been segmented into injectable, oral, and topical. Among these, oral treatment extensively popular and occupies a share of 40% in the global market.

By mode of drugs type, the global psoriasis treatment market has been segmented into biologics and small molecules. Among these, the biologics segment is likely to gain prominence in the coming years owing to their targeted actions.

Regional Insights

Geographically, the psoriasis treatment market span across regions namely, North America, Asia Pacific, Europe, and the Middle East & Africa.

North America is presumed to witness the largest share in the global market. The growth can be ascribed to the presence of several market giants coupled with a large patient population affected by psoriasis. This is in turn likely to generate more revenue for the market growth. People in this region are highly aware regarding the condition has resulted in an increased demand for effective treatment. Moreover, the surging R&D activities in order to develop a long-term solution for psoriasis is anticipated to encourage the market growth across the globe.

The Asia Pacific region is considered to expand at the fastest growth rate owing to the swiftly developing healthcare infrastructure coupled with the surging awareness regarding conditions like psoriasis. Moreover, with the affinity for natural skin care methods, effective alternative treatments can develop in order to treat such conditions.

Industry Updates

April 24, 2019: The FDA officials have recently approved risankizumab-rzaa which can effectively treat moderate-to-severe plaque psoriasis. The treatment has been specifically targeted for adults undergoing phototherapy or systemic therapy.

Competitive Dashboard

The prominent players operating in the global psoriasis treatment market comprises Johnson & Johnson, Novartis International AG, Merck and Co. Inc, Pfizer Inc, AbbVie and Amgen, and Eli Lilly.

Get access to full summary @ https://www.marketresearchfuture.com/reports/psoriasis-treatment-market-2769

Cell Therapy Market Future Technological Trends and Business Opportunities 2023

Market Synopsis:

Cells are transplanted into a patient’s body during cell therapy. These cells can either be extracted from the patient himself or another donor. It is used to cure different diseases and, therefore, has gained popularity among the population. Market Research Future (MRFR)’s assessment prognosticates that the global cell therapy market is set to reflect a CAGR of 22.36% during the forecast period 2018 to 2023.

Rising occurrences of diseases are expected to increase demand for cell therapy process for healing in the years to come. In addition, the market is poised to gain traction over the next couple of years owing to the accelerated research & development activities for the development of advanced cell therapies.

Cell therapy treatment is highly leveraged for curing cancer and is expected to witness rapid developments in the foreseeable future. It is poised to aid the proliferation of the cell therapy market across the review period. However, stringent legislation regulating the treatment is expected to undermine the proliferation of the cell therapy market in the near future.

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/5066

Market Segmentation:

By type, the global cell therapy market has been segmented into autologous and allogeneic.

By product, the cell therapy market has been segmented into Consumables (Vessel/Media/Serum/Reagent), and software & other services.

By technique, the global cell therapy market has been segmented into stem cell therapy, cell vaccine, Adoptive Cell Transfer (ACT), fibroblast cell therapy, and chondrocyte cell therapy.

By technology, the cell therapy market has been segmented into viral vector technology, cell immortalization technology, and genome editing technology.

By cell source, the global cell therapy market has been segmented into bone marrow, adipose tissue, and umbilical cord blood-derived cells.

By application, the cell therapy market has been segmented into oncology, cardiovascular disease (CVD), orthopedic and wound healing.

By end-user, the global cell therapy market has been segmented into hospital & clinics, regenerative medicine centers, and research institutes.

Regional Analysis:

The global cell therapy market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA). Cell therapy has already gained popularity in North America and is anticipated to strike a CAGR of 21.45% over the assessment period. It held the majority of the market share in 2017 accounting for 37.6% share and is forecasted to maintain its prominence across the projection period.

Europe is a crucial growth pocket and has been projected to scale a valuation of USD 6,357.79 by the end of 2023. The increasing healthcare expenditure is projected to drive the growth of the regional market in the forthcoming years.

Competitive Dashboard:

This MRFR report offers a detailed market share analysis which includes some of the key players, viz. Vericel Corporation, Mesoblast Ltd, Osiris Therapeutics, Inc, NuVasive, Inc., JCR Pharmaceuticals Co., Ltd, Pharmicell Co., Ltd, AlloSource, RTI Surgical Holdings, Inc., Holostem Terapie Avanzate S.r.l., and Medipost Co., Ltd.

Industry News:

In May 2019, Gilead Sciences Inc, an American biotechnology company that researches, develops and commercializes drugs, has announced that its cancer-focused cell therapy company which was acquired in 2017 will now operate as a separate business unit.

In May 2019, a draft has been proposed in China according to which some elite hospitals in the country would be able to sell experimental therapies that engineers patients’ cells for the treatment of diseases such as cancer.

In April 2019, Vineti Inc., a leading cloud-based platform has announced its partnership with Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, for supporting a diverse cell therapy portfolio.

In April 2019, scientists at the University of Bristol have developed cell therapy for diabetes which produces a glue-like hydrogel for making the stem cells last for a longer period.

Get access to full summary @ https://www.marketresearchfuture.com/reports/cell-therapy-market-5066

Antifungal Treatment Market is Projected to Bring in USD 19,558.0 million Revenues by 2023-End

Market Research Future has a cooked research report on the global antifungal treatment market. The global antifungal treatment market is expected to grow at a CAGR of 4.61% from 2017 to 2023.

Market HighlightsThe global antifungal treatment market is growing moderately and expected to grow at the same pace over the forecast period 2017-2013. Increasing number of patients with fungal diseases and growing prevalence of HIV are the key factors of the market growth. Additionally, rising geriatric population is one of the important drivers of the market growth.  

The global Antifungal treatment market is expected to grow at a CAGR of 4.61% during the forecast period and is estimated to reach USD 19,558.0 million by 2023.

Taste the market data and market information presented through more than 80 market data tables and figures spread over 108 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “anti-fungal treatment market research report–Global forecast till 2023.”

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/1628

Regional Analysis

The global antifungal treatment market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominate this market, pjk articularly, North America due to increasing cases of patients with fungal infections in this region. Furthermore, rapid adoption of new antifungal treatment methods and developed healthcare infrastructure propel the growth of the market.

Rising prevalence of fungal diseases is driving the growth of the European market. Most of the European companies are focusing more on research and development of the antifungal drugs, which, in turn, fortify their position in the global market. These companies receive a government funding from the government, which favors the growth of market in Europe.

Asia Pacific is expected to be the fastest growing region in this market owing to the developing healthcare infrastructure, increasing adoption of new medical practices, rising healthcare expenditure, growing awareness about available treatments for fungal infections.

The Middle East & Africa region is expected to grow slower than the global average due to lack of awareness about antifungal treatments and limited access to healthcare facilities.

Segmentation

The global antifungal treatment market has been segmented on the basis of drugs class, which includes azoles, pyrimidines, echinocandins, polyenes, allylamines, and others drugs.

On the basis of therapeutic indication, the market is segmented into systemic, candidiasis, coccidioidomycosis, and cryptococcosis.

On the basis of pathogen, the market is segmented into Candida, Aspergillus, Cryptococcus, Coccidioides immitis, Zygomycetes, Trichophyton, and others.

On the basis of end users, the market is segmented into hospitals & clinics, dermatology clinics and other users.

Major Players

Some of the key players in this market are Novartis AG (Switzerland), Pfizer Inc. (U.S), Sanofi (France), Merck & Co., Inc. (U.S), Astellas (Japan), Bayer AG (Germany)

Access Complete Report @ https://www.marketresearchfuture.com/reports/antifungal-treatment-market-1628 

Vaccine Adjuvants Market Expansion Projected to Gain an Uptick By 2023

Market Research Future has a half cooked research report on the global vaccine adjuvants market.

Market Highlights

Adjuvant is a substance that enhance the immune responses against antigens. More than one adjuvant may be present in the final vaccine products. Aluminum salts, such as aluminum hydroxide, aluminum phosphate, and aluminum potassium sulfate are widely used as an adjuvant in the vaccines production. Increasing demand for adjuvants to enhance and extend immune response, and need for development of safe and non-toxic adjuvants will boost the growth of the market. Moreover, increasing use of synthetic vaccines and recombinant vaccines are also expected to drive the global vaccine adjuvants market over the forecast period. Moreover, increasing demand for improved and long-lasting vaccination against existing and emerging diseases and increasing vaccination programs by the government and research and development activities favor the growth of this market in this region. On the other hand, high toxicity of adjuvants, and high developing cost for a new vaccine adjuvants may hamper the growth of the market.

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/1098

The global vaccine adjuvants market is expected to grow at a CAGR of 10.1% during the forecast period 2017-2023.

Taste the market data and market information presented through more than 105 market data tables and figures spread over 110 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “vaccine adjuvants market research report–Global forecast till 2023.”

Major Players in Vaccine adjuvants Market

Some of the key players in the global market are VaxLiant LLC.(U.S),Vaxine Pty Ltd (Australia), Aphios Corporation (U.S), Viscogel AB (Sweden), Adjuvatis (France), Sergeant Adjuvants (U.S), Sigma-Aldrich Co. LLC.(India), CureVac AG (Germany), Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (Fracne), Agenus, Inc. (U.S), Novavax, Inc.(U.S), SPI Pharma, Inc.(U.S), Invivogen (U.S), Avanti Polar Lipids, Inc. (U.S), MPV Technologies (U.S), and  OZ Biosciences (France). 

Regional Analysis

The global vaccine adjuvants market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the global market due to major initiatives taken by the government for vaccination against many diseases as well as excellent management of public awareness programs. Europe is the second largest market owing to increased emphasis and availability of funds for research and development. The government is campaigning about vaccination and various preventive measures against infectious and non-infectious diseases. Recently, governments in developing countries of Asia Pacific have undertaken various vaccinations programs to the educate people. India is expected to be an emerging and the fastest growing market due to increasing focus on immunization programs by various government and NGOs. The market shows steady growth in the Middle East & Africa due to lower demand for vaccine adjuvants as compared to other regions across the globe.

Segmentation

The global vaccine adjuvants are segmented by types, routes of administration, and end users. On the basis of types, it is segmented into pathogen components, particulate adjuvants, and others. On the basis of routes of administration, it is segmented into oral, intramuscular, subcutaneous, and intradermal. On the basis of end users, it is segmented into pediatric, adult.

Access Complete Report @ https://www.marketresearchfuture.com/reports/vaccine-adjuvants-market-1098

DNA Sequencing Market - Segmentation and Major key Players Analysis By 2023

Market Highlights

DNA sequencing contains information about genetically determined illness and IQ level of human beings. Increasing adoption of precision medicines and increasing use of other applications such as biotechnology, forensic biology, virology, and molecular biology are factors which are driving the growth of this market. The rise in investment in research and development enhances the demand for DNA sequencing and hence helps to increase market growth. The enzymic method for DNA sequencing has been used for genomic research and as accurate results were obtained by this method the demand for DNA sequencing has increased. This demand has driven the development of the second-generation sequencing method.

However, the lack of reimbursement policies in various countries across the world may limit the growth of this market during the forecast period.   

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/5774  

  

Regional Analysis

The market in the Americas is expected to boost the global DNA sequencing market owing to technological advancements and increasing incidences of genetic disorders among patients. Increasing investments by government organizations in the research and development of DNA sequencing are also boosting the market growth in this region. The European market is expected to be the second-largest due to government funding and support from the healthcare sector coupled with the rising prevalence of the genetic disorder. However, Asia-Pacific is projected to dominate in terms of growth rate over the forecast period owing to the rising investment towards R&D activities and unhealthy lifestyle which are resulting in an increased prevalence of cancer and other disorders. Rising geriatric population and increasing prevalence of tumor among patients in this region have a positive influence on the development of DNA sequencing market in this region.  The Middle East and Africa accounts for the smallest share due to lack of medical technology and poor medical facilities. Emerging economies such as India and China are leading to growth in the demand for DNA sequencing owing to an increasing number of healthcare awareness programs, government investments in healthcare, and favorable healthcare insurance coverage.  

Segmentation

The global DNA sequencing market has been segmented on the basis of type, product, technology, application, and end-users. On the basis of type, the market is segmented into instruments and consumables services and workflow products. Based on product the market is segmented into sequencing services and sequencing instruments and consumables. Sequencing instruments and consumables are further sub-segmented into two types such as sequencing instruments and consumables by product type and by platform type. Sequencing instruments and consumables by product type are further sub-segmented into consumables, instruments, whereas sequencing instruments and consumables by platform type are further sub-segmented into NGS, sanger, bioinformatics, sample prep kits, and reagents. On the basis of technology, the market is further segmented into semiconductor sequencing, pyrosequencing, sequencing by synthesis, single-molecule real-time sequencing (SMRT), sequencing by ligation (SBL), and other technologies. On the basis of application, the market is further segmented into diagnostics, agriculture and animal research, biomarker discovery, personalized medicine, drug discovery, and other applications. Based on end-user, the market is segmented into research centers and government institutes and academia, biotechnology and pharmaceutical companies, clinics and hospitals, and other end-users.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

Key Players

Some of the key players in the global DNA sequencing market are Perkin Elmer, Roche Holdings AG, Siemens AG, Illumina, Agilent Technologies Inc., Genia Corporation, Oxford Nanopore technologies, Koninklijke Philips N.V., Pacific Biosciences, Johnson & Johnson, Deep Genomics, Inc., Life Technologies, Illumina, Eppendorf, Tecan, and Thermo Scientific, Hamilton Thorne Biosciences, General Electric Company, Siemens Healthineers GmbH, Myriad Genetics, Bayer Corporation, Beckman Coulter, and others.

Access Report @ https://www.marketresearchfuture.com/reports/dna-sequencing-market-5774

About Market Research Future:

Surgical Site Infection Control Market Growth Projected to Amplify By 2023

Market Research Future published a half-cooked research report on the global surgical site infection control market.

Market Highlights

The global surgical site infection control market is expected to grow at an approximate CAGR of 6.7% during the forecast period, 2018–2023. This growth is attributed to the development of technologically advanced products, an increase in hospital-acquired infections and rapidly increasing geriatric population are fuelling the market growth. However, the rise in use of outpatient treatment and lack of awareness of hospital infection prevention and control are hampering the market growth

.

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/7830

Segmentation

The global surgical site infection control market is segmented based on product, procedure, type of infection, end user, and region.

On the basis of product, the market is segmented into manual reprocesses solution, disinfectants, surgical scrubs, surgical drapes, skin preparation solution, medical nonwovens, surgical gloves, and others. The disinfectants are segmented into hand disinfectants and skin disinfectants. On the basis of procedure, the market is segmented into cataract surgery, caesarean section, dental restoration, gastric bypass, and others.  On the type of infection, the market is segmented into superficial incisional SSI, deep incisional SSI organ or space SSI. On the basis of end user, the market is segmented into hospitals and ambulatory surgical centres.

Regional Analysis

The Americas leads the global surgical site infection control market. This growth can be attributed to increasing awareness of surgical site infections, presence of key players, availability of sophisticated infrastructure and the increasing initiatives to curb all types of infection after surgeries. Moreover, the presence of developed economies like the US and Canada within the region boost market growth.

In 2017, followed by the Americas, Europe stood second in the global market owing to the presence of well-developed healthcare infrastructure, increasing awareness and high healthcare expenditure. According to a survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011-2012 by European Centre for Disease Prevention and Control (ECDC), the burden of surgical site Infections in the European Union was estimated at 5,43,149 cases annually.

Asia-Pacific was estimated to be the fastest growing region in 2017. This can be attributed due to the high contamination rate, increasing household income and growing penetration of the market players within the region. Moreover, a rapidly growing pharmaceutical sector within the region boosts the market to grow.

On the other hand, the Middle East and Africa held the least share in the global surgical site infection control market. This can be attributed due to the presence of poor economies, stringent government policies and low per capita income, especially within the African region. A majority of the market share within the Middle East & Africa is estimated to be held by the Middle East due to increasing government funding for healthcare, improving healthcare facilities and presence of developed economies like United Arab Emirates, Saudi Arabia, Kuwait, Dubai, and others.

Key Players

Some of the key players in the global surgical site infection control market are 3M, Becton Dickinson and Company, Belimed AG, bioMerieux SA, Getinge Group, Johnson & Johnson, Kimberly-Clark Corporation, Sotera Health, Ansell Limited, Steris Corporation, Lac-Mac Limited, Pacon Manufacturing Corp, American Polyfilm Inc., and others.

Get Complete Report Details@ https://www.marketresearchfuture.com/reports/surgical-site-infection-control-market-7830

Fluoroscopy and Mobile C-Arms Market is projected to expand at a robust CAGR of 4.58% By 2023

Market research future will be publishing a cooked research report on “Global Fluoroscopy and Mobile C-Arms Market” that contains the information from 2015 to 2023. The global fluoroscopy and mobile c-arms market is expected to register at a CAGR 4.58% during the forecast period of 2018­­–2023

Market Research Future (MRFR) recognizes the following companies as the key players in the global fluoroscopy and c-arms market that includes Allengers Medical Systems (India), Canon Medical Systems Corporation (Japan), DMS Group (France), GE Healthcare (US),     Hitachi Ltd (Tokyo), Hologic Inc. (US), Omega Medical Imaging, LLC (US), OrthoScan, Inc. (US), Koninklijke Philips N.V. (The Netherlands), Shimadzu Corporation (Japan), Siemens (Germany), Varian Medical Systems, Inc. (US), Villa Sistemi Medicali Spa (Italy), and Ziehm Imaging GmbH (US).

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/7717

Market Highlights

The Global Fluoroscopy and Mobile C-Arms Market is expected to register a CAGR of 4.58% and is anticipated to reach USD 2,951.4 million by 2023. Fluoroscopy is a medical imaging technique which displays multiple x-rays to generate real-time images or a video of the patient’s body. Fluoroscopy and mobile c-arms systems are used in a broad range of interventional radiological procedures, especially in the treatment of conditions such as spinal cord injury, pulmonary embolism, deep vein thrombosis, abdominal aortic aneurysms, and other disease ailments.

The rising prevalence of chronic diseases, growing geriatric population, and rising adoption of fluoroscopy in orthopedic and neurological procedures are some factors propelling the growth of the market. Despite the drivers, the high cost associated with fluoroscopic and mobile c-arm systems, the risk of radiation exposure, and presence of substitutes are some factors that are likely to hinder the growth of the market over the assessment period.

Segment Analysis

The global fluoroscopy and mobile c-arms market has been segmented into device type, application, and end user. On the basis of device type, the global fluoroscopy and mobile c-arms market has been segmented into fluoroscopy systems and mobile c-arms. Based on application, the market has been segmented into gastrointestinal, orthopedics, pain management and trauma, cardiovascular, neurology, urology, and others. By end user, the market has been segmented into hospital and clinics, diagnostic centers, research and academic institutes, and others. The hospital and clinics segment is accounted for a market value of USD 895.96 million in 2017.

Regional Analysis

Geographically, the Americas is expected to dominate the global fluoroscopy and mobile c-arms market. In this region, North America is expected to dominate the market owing to the acceptance of new and innovative products, the growth in awareness about medical imaging devices, and growing financial capability to purchase expensive machines. Europe showed a significant amount of growth in the market due to the rising incidences of road accidents leading to the increasing number of orthopedic surgeries in the European region, increased expenditure in the healthcare sector, and growing R&D activities. Asia-Pacific is estimated to be the fastest growing region in the market. The developing economies of China, India, and South Korea are emerging as major destinations for outsourcing clinical trials and pathology testing. According to MRFR Analysis, China accounted for about 19.6% share in the Asia-Pacific region in 2017. Furthermore, the Middle East & Africa has the least share of the global fluoroscopy and mobile c-arms market due to the low disposable income and poor healthcare infrastructure.

Key Findings of the Study

• Global fluoroscopy and mobile c-arms market is projected to reach USD 2,951.4 million by 2023 with 4.58% CAGR during the review period of 2018 to 2023
• The Americas accounted for the largest share in the region due to the high adoption rate of fluoroscopy in surgical procedures.
• The hospital and clinics segment is accounted for the largest share, holding a market value of USD 895.96 million in 2017.
• Some of the players operating in the fluoroscopy and c-arms market include Allengers Medical Systems, Canon Medical Systems Corporation, DMS Group, GE Healthcare, and Hitachi Ltd, among others.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/fluoroscopy-mobile-c-arms-market-7717